Algeria’s first bioequivalence study for a drug

Yesterday, Sunday, in Algiers, the Algerian bioequivalence center “Equival Biocenter” presented its first bioequivalence study to demonstrate the therapeutic efficacy of a generic antibiotic produced by the state-owned pharmaceutical group “Saidal”. Read more…

Towards pharmaceutical self-sufficiency

Algeria has taken a crucial step in its strategy of pharmaceutical self-sufficiency, with the official inauguration of the second private bioequivalence center launched by Clinica Group. Read more…

Inauguration of a state-of-the-art control laboratory

Algeria has taken a decisive step forward in the pharmaceutical sector with the inauguration of a new state-of-the-art central laboratory at the Agence Nationale des Produits Pharmaceutiques (ANPP). Read more…